Electrochemical sensor improves sensitivity and selectivity for dopamine detection, suggesting potential clinical applications.
Dopamine (DA) is a key neurotransmitter in the central nervous system, and abnormal concentrations are associated with a variety of diseases. In this study, a novel electrochemical sensor is constructed based on ultrathin P-doped MoS2/MoO2 nanosheets supported on bowl-shaped N-doped carbon hemispheres (N-BCH@P-MoS2/MoO2). The unique hierarchical structure combines the high specific surface area of N-BCH with the enhanced electrocatalytic activity of P-doped MoS2/MoO2, resulting in significant improvements in the performance for DA detection. The electronic structure of the catalyst is further modulated by the codoping of N and P, which increases the electrical conductivity and the number of active centers. The results show that the N-BCH@P-MoS2/MoO2 exhibits excellent sensitivity and selectivity for DA detection, capable of achieving a detection limit as low as 0.12 μM within a broad concentration range (3-100 μM) (S/N = 3). Furthermore, electrocatalysts have been employed in the detection of DA in human serum, indicating significant promise for clinical diagnosis.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: